CEO Volker Herrmann (Inzen)
Flagship christens the latest startup to join the drug discovery fleet, this time focused on the lessons of cell death
A few years ago, Flagship managing partner Doug Cole began to pick at the notion that cell death could offer a rich source of information …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
